ANI Pharma (Nasdaq: ANIP) disclosed the following on Tuesday:Item 2.03 Creation of a Direct Financial Obligation or ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE